Verticals / Pharma, medtech & health distribution / Merck & Co Inc
Merck & Co Inc
merck.com ↗—
Latest disclosed NPS
no score published
0
NPS entries
0 with a number
2026
Years covered
1 entries in all
In their words
“Merck & Co. reports 95% renewal rate for veterinary implant products.”
NPS disclosures (0)
No NPS disclosures yet.
Retention disclosures (1)
28 Oct 2026
Retention95%
Merck & Co. reports 95% renewal rate for veterinary implant products.
— reported by marketsandmarkets.com · 28 Oct 2026 · NI-33A3545
marketsandmarkets.com ↗2 earlier entries are in the full version. Get full access →
Lighthouse companies in Pharma, medtech & health distribution
About these figures
Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.
NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.